Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SUMMER INFAN | SUMR | 9.94% |
| SCIENTIFIC L | SCIL | 8.00% |
| NEW ORIENTAL | EDU | 5.80% |
| FEDERAL MOGU | FDML | 5.80% |
| NATUS MEDICA | BABY | 5.69% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We reiterate our Neutral recommendation on Rockwell Automation Inc. ( ROK - Analyst Report ) . The company missed both the earnings and revenue estimates in the second quarter of fiscal 2012.
Rockwell Automation’s earnings of $1.16 a share improved 2% from the prior year quarter's earnings of $1.14, but fell short of the Zacks Consensus Estimate by 11 cents. Total revenue grew 7% year over year to $1.56 billion, missing the Zacks Consensus Estimate of $1.57 billion.
Rockwell Automation has recently hiked the quarterly dividend by 11% to 47 cents per share, adding value to the shareholders. Its commitment towards increasing shareholders’ return reflects its free cash flow generating capability and a strong balance sheet.
Further, the company’s Board has approved the addition of $1 billion to its share repurchase program. This is in addition to the previous buy-back authorization of $1 billion, of which the company had $51 million remaining as of June 7, 2012.
During the second quarter, Rockwell repurchased 0.5 million shares for $40.6 million. The company expects to repurchase nearly 3 million shares for the balance of the year. A lower share count would turn out to be a tailwind for earnings for the forthcoming quarters.
Rockwell Automation is experiencing strong growth in the Process business which grew 20% year over year in the second quarter. The segment is benefiting from a strong execution in Logix.
The company introduced two new Logix-mid range controller platforms that will help in improving scalability and Ethernet connection. Moreover, it has plans to invest in Logix and expand the served market. Logix sales are expected to grow more than $1 billion in fiscal 2012.
However, macroeconomic conditions might place the company in a difficult situation in fiscal 2012. Moderating global economic growth and uncertainty in the global economic scenario can lead to cautious capital spending in fiscal 2012, limiting Rockwell’s near-term revenue visibility.
The company has narrowed its sales guidance to the range of $6.25-$6.45 million from the previous guidance of $6.2-$6.5 million. Based on the projected sales, the company has narrowed the earnings per share target to $5.10-$5.40 from the previous estimate of $5.05-$5.45.
Further, currency will pose a problem for the balance of the year. Currency translation is expected to reduce sales by 2 percentage points in fiscal 2012.
Rockwell Automation faces competition from ABB Ltd. ( ABB - Snapshot Report ) , Siemens AG ( SI - Analyst Report ) and Emerson Electric Co. ( EMR - Analyst Report ) . The stock retains a short-term Zacks #4 Rank (Sell).
Read the full Analyst Report on SI
Read the full Snapshot Report on ABB
Read the full Analyst Report on EMR
Read the full Analyst Report on ROK